GFM
PCVX icon

GF Fund Management’s Vaxcyte PCVX Stock Holding History

GF Fund Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
3,048
+108
+4% +$5.87K ﹤0.01% 287
2026
Q1 		$171K Buy
2,940
+368
+14% +$20K ﹤0.01% 296
2025
Q4 		$119K Sell
2,572
-221
-8% -$9.88K ﹤0.01% 335
2025
Q3 		$101K Sell
2,793
-399
-13% -$13.2K ﹤0.01% 336
2025
Q2 		$104K Hold
3,192
– – ﹤0.01% 361
2025
Q1 		$121K Buy
3,192
+575
+22% +$46K ﹤0.01% 351
2024
Q4 		$214K Buy
+2,617
New +$260K ﹤0.01% 287

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GF Fund Management's PCVX Position: Q2 2026 in Review

GF Fund Management increased its Vaxcyte (PCVX) stake by 3.7% in Q2 2026, buying an estimated $5.87K and bringing the position to 3,048 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

GF Fund Management first reported a position in PCVX in Q4 2024 and has held it in 7 quarters since. The position peaked at $214K in Q4 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • GF Fund Management held 3,048 shares of Vaxcyte worth $177K as of Q2 2026.
  • GF Fund Management bought 108 Vaxcyte shares in Q2 2026, an estimated $5.87K.
  • Vaxcyte made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #287 holding.
  • GF Fund Management first reported a position in Vaxcyte in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Vaxcyte position peaked at $214K in Q4 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.